Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-07

Clinical Trial Update: To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the protective effect of a fixed combination of disodium cromoglycate and reproterol in asthma with exercise-induced symptoms; study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Disodium cromoglycate + reproterol fixed combination

Snippet

Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Asthma, Exercise-Induced | Phase 2 | Status: COMPLETED